Biopreservation Market

I believe that there is a dire need for designing and manufacturing a generic biopreservation media that can be used for the preservation of different types of biological specimen, for shorter as well as longer durations. Companies offering such media are likely to witness lucrative market opportunities in the longer term as well

-- CEO, Europe based small-sized company

Biopreservation Market Overview

The biopreservation market for media, valued at USD 1.9 billion in 2025, is projected to reach USD 2.3 billion in 2026 and USD 15.5 billion by 2035, with a 23.6% CAGR during the forecast period 2026 to 2035. Over the past few years, there has been an evident growth in the pipeline of cell-based products, fueled by the demand for effective therapeutics. However, such products are often temperature sensitive, requiring freezing / cryogenic conditions for transport and storage. In fact, as per a study conducted by the USFDA, across more than 80% submissions for mesenchymal cell-based therapies, it was reported that such products required cryopreservation.

To learn more about this report, request a free sample copy

Therefore, there is a need to identify preservation strategies that are capable of potentially protecting the genome and proteome profiling while avoiding stress-related genetic selectivity, which is a condition that most of the current preservation methods fail to meet.

Further, the chosen method should enable speedy restoration to normal physiological function. Specifically, the presence of components, such as animal-derived products, serum and proteins, often acts as a bottleneck for the effective preservation of biological samples. Biopreservation can address a number of product-related concerns by successfully combining engineering concepts with advances in cellular and molecular biology. As a result, there has been a shift in the interest of industry stakeholders towards pre-formulated, commercially available biopreservation media, which have already been checked for their quality, efficacy, safety, post preservation high cell recovery, clinical applicability and cost effectiveness. For compatible freezing workflows, cryopreservation bags provide primary containment and must be selected alongside the preservation medium and storage protocol.

At present, over 60 players claim to offer more than 190 biopreservation and biobanking, intended for storage and preservation of different types of biological samples. Recent trends indicate that the biopreservation market is expanding at a rapid rate, as improvements in adjacent disciplines, such as stem-cell research, cell therapy, personalized medicine, cell banking and cancer research, are fueling the need for ameliorated storage techniques for biologics. For instance, Kite Pharma enhanced the stability of its primary oncological product (axacabtagene ciloleucel) from 18 hours to 2 weeks, by transitioning the product to cryopreserved state, easing production limitations and giving logistical flexibility at a lower overall cost. This further provides an opportunity for stakeholders to bring ingenious, improved and relatively economical biopreservation media in the market. It is worth highlighting that the biopreservation and biobanking providers are collaborating with other players in the reparative medicine industry to ensure safe and reliable outcomes. Considering the ever-lasting need for storage and transport of biological samples, as well as supported by the continuous endeavors of the biopreservation media providers to improvise their portfolio, we anticipate an upsurge in the market growth of biopreservation industry during the forecast period.

Key Companies in Biopreservation Market Developing Media 

Examples of key companies engaged in biopreservation market (which have also been profiled in this market report; the complete list of companies is available in the full report) include BioLife Solutions, Cell Applications, HiMedia Laboratories, Merck, Thermo Fisher Scientific, United States Biological and ZenBio. This report by Roots Analysis on biopreservation industry includes an easily searchable excel database of all the companies providing biopreservation and biobanking, worldwide.

Recent Developments in Biopreservation Market

Several recent developments have taken place in the field of biopreservation. We have outlined some of these recent initiatives below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that have been outlined in our analysis.

• In February 2026, Johnson & Johnson invested USD 1 billion in a new cell therapy manufacturing plant in Pennsylvania. This is part of their USD 55 billion US commitment by 2029. The facility will create 4,000 construction jobs and 500 biomanufacturing jobs, while supporting bio preservation for advanced therapies.
• In November 2025, BioLife Solutions announced the opening of Aby J. Mathew Center for Biopreservation Excellence. This facility focuses on improving bio preservation processes through training, workshops, and R&D.

Scope of the Biopreservation Market Report

The “Biopreservation Market by Preservation Condition (Refrigerated, Frozen / Cold Chain, Frozen (Ultra-low) / Deep Frozen, and Cryogenic / LN2 Vapor Phase Storage), Type of Serum (Fetal Bovine Serum Containing Media, Fetal Calf Serum Containing Media, Human Serum Containing Media, and Serum Free Media), Type of Biological Sample (Germline Cells / Stem Cells, Organs, Somatic Cells, and Tissues), Area of Application (Diagnostic Use, Research and Development, and Therapeutic Use), Type of Packaging Format (Bags, Bottles, Vials, and Others), End Users (Academic and Research Institutes, Biobanks / Genebanks, Hospitals, Pharmaceutical and Biotechnology Companies, and Other End Users), and Region (North America, Europe, Asia, MENA, Latin America, and Rest of the World): Industry Trends and Global Forecasts, Till 2035”  market report offers an elaborate study of the current market landscape, market size, market forecast and future opportunities of the biopreservation industry during the forecast period. The market research report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in the domain of biopreservation market.

Amongst other elements, the market report includes:

• A detailed overview of the current biopreservation media providers’ landscape, including information on the year of establishment, company size, type of company and location of headquarters. In addition, it presents the current market landscape of biopreservation media based on several relevant parameters, such as preservation condition, type of serum, type of biological sample, area of application, type of packaging format, packaging volume and product price.
• An in-depth analysis of the contemporary market trends, presented using five schematic representations, including [A] a world map representation highlighting the location of headquarters, [B] a 4D bubble chart comparing the leading players engaged in offering biopreservation media based on the parameters, such as year of establishment, company size, number of biopreservation media offered and region, [C] an insightful treemap representation of biopreservation media, distributed on the basis of preservation condition and area of application, [D] a grid representation illustrating the distribution of biopreservation media based on company size, region, preservation condition, type of serum and type of biological sample, and [E] a heat map representation of biopreservation media, distributed on the basis of minimum packaging volume and minimum price.
• An in-depth company competitiveness analysis of biopreservation media providers, taking into consideration various relevant parameters, such as years of experience, product portfolio strength (in terms of preservation condition, presence of serum, type of biological sample, maximum packaging volume and area of application), and partnership activity (in terms of number of partnerships and type of agreements).
• Elaborate profiles of various prominent players that are engaged in offering biopreservation media, featuring a brief overview of the company (including information on year of establishment, number of employees, location of headquarters and key members of the executive team), recent developments and an informed future outlook.
• An analysis of the partnerships that have been inked between various stakeholders in biopreservation market, since 2015, covering manufacturing and supply agreements, product distribution agreements, product development agreements, acquisitions and other agreements.
• A Bowman’s strategy clock framework to understand the pricing strategy of the biopreservation media offered by the company along with its competitive position. In addition, it presents the equation devised to calculate the likely price of the biopreservation media based upon its characteristics.

One of the key objectives of this market report is to provide a detailed market forecast analysis in order to estimate the existing market size and future opportunity associated with biopreservation market during the forecast period. Based on multiple parameters, such as likely adoption trends, revenues of biopreservation media providers, and expected price variations for these media, we have provided an informed estimate on the evolution of the market for the forecast period till 2035.

The market report also features the likely distribution of the current and forecasted opportunity within biopreservation media providers market across

• Preservation condition (cryogenic / LN2 vapor phase, frozen (ultra-low) / deep frozen, frozen / cold chain, and refrigerated),
• Type of serum (fetal bovine serum containing media, fetal calf serum containing media, human serum containing media, and serum free media),
• Type of biological sample (germline cells / stem cells, organs, somatic cells, and tissues), [D] area of application (diagnostic use, research and development, and therapeutic use),
• Type of packaging format (bags, bottles, vials, and others),
• Tnd users (academic and research institutes, biobanks / genebanks, hospitals, pharmaceutical and biotechnology companies, and other end users), and
• Region (North America, Europe, Asia, MENA, Latin America, and Rest of the World).

In order to account for future uncertainties and to add robustness to our forecast model, we have provided three market forecast scenarios, portraying the conservative, base and optimistic scenarios, representing different tracks of the industry’s growth. All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this market research report are in USD, unless otherwise specified.